http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9427629-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_174517327ba892ca9e3876c789505079
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 1994-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffee0947a84b50913d5c7afdbbf0726a
publicationDate 1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9427629-A1
titleOfInvention Method to control appetite and treat obesity
abstract The present invention relates to the administration of human apolipoprotein A-IV, isoforms and active fragments thereof, to humans as an injectable formulation for the purpose of controlling appetite and reducing food intake and body weight. The invention is also directed to an injectable pharmaceutical formulation of human apolipoprotein A-IV, or active fragments thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084800-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004084800-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9266941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525749-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9730980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840688-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9951120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525749-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232019-B2
priorityDate 1993-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5013722-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228962621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127759454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128334456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12040205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68431475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128898221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175

Total number of triples: 59.